Diabetes awareness survey reveals alarming figures across the Middle East and Northern Africa regions
- Details
- Category: Novo Nordisk
![Novo Nordisk Novo Nordisk](/images/stories/logo/novonordisk_b.gif)
Collaboration of Boehringer Ingelheim and VTU Technology
- Details
- Category: Boehringer Ingelheim
![Boehringer Ingelheim Boehringer Ingelheim](/images/stories/logo/boehringeringelheim.gif)
Bristol-Myers Squibb Foundation Launches $100 Million Initiative Targeting America's Type 2 Diabetes Crisis
- Details
- Category: Bristol-Myers Squibb
![Bristol-Myers Squibb Bristol-Myers Squibb](/images/stories/logo/bms.gif)
Nycomed is keeping the pace in third quarter 2010
- Details
- Category: Nycomed
![Nycomed Nycomed](/images/stories/logo/nycomed.gif)
Alpine Mountaineer and Alzheimer's Advocate to Climb Highest Peak on Each Continent
- Details
- Category: Pfizer
![Pfizer Inc. Pfizer Inc.](/images/stories/logo/pfizer_b.gif)
Roche reports promising Phase II results with new targeted approach in advanced melanoma
- Details
- Category: Roche
![Roche Roche](/images/stories/logo/roche.gif)
Genzyme Responds to Sanofi-Aventis Letter
- Details
- Category: Genzyme
![Genzyme Corp. Genzyme Corp.](/images/stories/logo/genzyme.gif)
More Pharma News ...
- Sanofi-aventis Sends Letter to Genzyme Seeking Clarification on Potential Board Actions
- Abbott Remains on the Dow Jones Sustainability Indexes for the Sixth Consecutive Year
- Bayer raises its brand profile
- KOMBIGLYZE™ XR tablets approved in the US
- Amgen, Pfizer, and World-Class Professional Golfer Phil Mickelson Announce Partnership
- Prolia(TM) (denosumab) Receives Best New Drug Honor at Scrip Awards
- New data show potential for Novartis Meningitis B vaccine (4CMenB) candidate